2012

(2012) Baatz H. Kataraktchirurgie und altersbedingte Makuladegeneration. Klin Monbl Augenheilkd. 2012 Jan 12. [Epub ahead of print] DOI: 10.1055/s-0031-1280459

(2012) Raoul W, Poupel L, Tregouet DA, Lavalette S, Camelo S; Keller N, Krumeich S, Calippe B, Guillonneau X, Behar-Cohen F, Baatz H, Combadière C, Théry C, Sennlaub F. MFGE8 does not influence chorio-retinal homeostasis or choroidal neovascularization in vivo. PLoS ONE 7(3): e33244. doi:10.1371/journal.pone.0033244.

(2012) Mirshahi A, Höhn R, Lorenz K, Kramann C, Baatz H. Anti-Tumor Necrosis Factor Alpha for Retinal Diseases: Current Knowledge and Future Concepts. J Ophthalmic Vis Res 2012; 7 (1)

2011

(2011) Prada J, Schruender S, Ngo-Tu T, Baatz H, Hartmann C, Pleyer U. Expression of tumor necrosis factor-α and interleukin-6 in corneal cells after excimer laser ablation in Wistar rats. Eye (Lond). 2011 Apr;25(4):534-6

2010

(2010) Pavlidis M, Scharioth G, de Ortueta D, Baatz H. Iridolenticular block in heavy silicone oil tamponade. Retina. 2010 Mar;30(3):516-20.

(2010) Baatz H, Raak P, de Ortueta D, Mirshahi A, Scharioth G. Praktische Bedeutung der Flimmerfusionsfrequenz (CFF). Zeitliche Auflösung des visuellen Systems in der Differenzialdiagnose. Ophthalmologe. 2010 Aug;107(8):715-9
2009
(2009) de Ortueta D, Arba Mosquera S, Baatz H., Aberration-neutral ablation pattern in hyperopic Lasik with the ESIRIS laser platform., J Refract Surg. 2009 Feb;25(2):175-84.

(2009) de Ortueta D, Arba Mosquera S, Baatz H., Comparison of standard and aberration-neutral profiles for myopic Lasik with the SCHWIND ESIRIS platform., J Refract Surg. 2009 Apr;25(4):339-49.

(2009) Mirshahi A, Baatz H., Posterior segment complications of laser in situ keratomileusis (Lasik)., Surv Ophthalmol. 2009 Jul-Aug;54(4):433-40.

(2009) Hattenbach LO, Friedrich Arndt C, Lerche R, Scharrer I, Baatz H, Margaron F, Richard G, Behrens-Baumann W, Ohrloff C., Retinal vein occlusion and low-dose fibrinolytic therapy (R.O.L.F.): a prospective, randomized, controlled multicenter study of low-dose recombinant tissue plasminogen activator versus hemodilution in retinal vein occlusion., Retina. 2009 Jul-Aug;29(7):932-40.

(2009) Baatz H, Poupel L, Coudert M, Sennlaub F, Combadiere C., Komplementfaktor-Polymorphismen und altersassoziierte Makuladegeneration in einer Gruppe deutscher Patienten., Klin Monbl Augenheilkd. 2009 Aug;226(8):654-8.

(2009) Mirshahi A, Höhn F, Baatz H, Müller M, Hattenbach LO., Periphere exsudative hämorrhagische Chorioretinopathie: Klinische und
angiographische Befunde., Klin Monbl Augenheilkd. 2009 Aug;226(8):659-63.

2008

(2008) Schreyger F, Scharioth G, Baatz H., SKGEL ® Implant versus T-Flux ® Implant in the Contralateral Eye in Deep Sclerectomy with Phacoemulsification: Long-Term Follow-Up. Open Ophthalmol J. 2008 Mar 28;2:57-61.

(2008) de Ortueta D, Arba-Mosquera S, Baatz H.,
Topographic changes after hyperopic Lasik with the SCHWIND ESIRIS laser platform., J Refract Surg. 2008 Feb;24(2):137-44.

(2008) Baatz H, Darawsha R, Ackermann H, Scharioth GB, de Ortueta D, Pavlidis M, Hattenbach LO., Phacoemulsification does not induce neovascular age-related macular degeneration. Invest Ophthalmol Vis Sci. 2008 Mar;49(3):1079-83.

(2008) Hattenbach LO, Kuhli-Hattenbach C, Scharrer I, Baatz H., Intravenous thrombolysis with low-dose recombinant tissue plasminogen activator in central retinal artery occlusion., Am J Ophthalmol. 2008 Nov;146(5):700-6. Epub 2008 Aug 21.

2007

(2007) Baatz H, Lange S, Buchner H, Scharioth G
Pseudoangiitis bei beidseitiger okulärer Ischämie.
Ophthalmologe (2007) 104:243-5.

(2007) Baatz H, Scharioth G, de Ortueta D, Pavlidis M,
Age Distribution of Patients Presenting with Uveitus. The Open Ophthalmology Journal (2007), 1, 23-24.

2006

(2006) Baatz H, Mirshahi A, Puchta J, Gümbel H, Hattenbach LO.
Reactivation of toxoplasma retinochoroiditis under atovaquone therapy in an immunocompetent patient.
Ocul Immunol Inflamm. (2006)14:185-7.

(2006) Mirshahi A, Scharioth GB, Klais CM, Baatz H.
Enhanced visualization of acute macular neuroretinopathy by Heidelberg Retina Tomography.
Clin Experiment Ophthalmol. (2006) 34:596-9.

(2006) D. De Ortueta, F. Schreyger, H. Baatz
Band keratopathy: A modified treatment.
Eur J Ophthalmol (2006) 16: 618 — 620

(2006) M. Zierhut, H. Baatz, S. Coupland, C. Deuter, A. Heiligenhaus, C. Heinz
Die Uveitis des alternden Menschen.
Ophthalmologe (2006) 103: 765–772

(2006) A. Mirshahi, G.B. Scharioth, D. de Ortueta, H. Baatz
Hinterabschnittskomplikationen der Laser-in-situ-Keratomileusis (Lasik) — Eine Literaturübersicht.
Klin Monatsbl Augenheilkd (2006) 223: 721-725

2005

(2005) 219:54-55
Puchta J, Baatz H
Intraocular Levels of Methotrexate after Oral Low-Dose Treatment in Chronic Uveitis Ophthalmologica

(2005) Mirshahi A, Schreyger F, Baatz H, Scharioth GB
Makula-Translokation nach photodynamischer Therapie: ein Fallbericht.
Klin Monatsbl Augenheilkd. (2005) 222:586-9

(2005) Ludwig RJ, Zollner TM, Santoso S, Hardt K, Gille J, Baatz H, Johann PS, Pfeffer J, Radeke HH, Schon MP, Kaufmann R, Boehncke WH, Podda M.
Junctional Adhesion Molecules (JAM)-B and -C Contribute to Leukocyte Extravasation to the Skin and Mediate Cutaneous Inflammation.
J Invest Dermatol. (2005)125:969-76.

2004

(2004) J Invest Dermatol. 122(3):830-836
Ludwig RJ, Schultz JE, Boehncke WH, Podda M, Tandi C, Krombach F, Baatz H, Kaufmann R, von Andrian UH, Zollner TM
Activated, not resting, platelets increase leukocyte rolling in murine skin utilizing a distinct set of adhesion molecules.

(2004) Journal of Medical Virology 73:250-255
Preiser W, Doerr HW, Buxbaum S, Rabenau HF, Baatz H
Acute Retinal Necrosis Six Years After Herpes Simplex Encephalitis: An Elusive Immune Deficit Suggested by Insufficient Test Sensitivity.

(2004) Ophthalmologe 101:1236-1238
Mirshahi A, Scharioth GB, Baatz H
Flächige weiße Ablagerungen auf der Netzhaut.

(2004) Der Ophthalmologe (Suppl. 1) 101:S412
Baatz H, Doerr HW, Buxbaum S, Rabenau HF, Preiser W
Akute Netzhautnekrose nach Herpes-Enzephalitis: Diagnostische Fallgrube bei der Herpes-Serologie.

2003

(2003) British Journal of Ophthalmology 87(5):548-550
Prada J, Noelle B, Baatz H, Hartmann C, Pleyer U
Tumour necrosis factor alpha and interleukin 6 gene expression in keratocytes from patients with rheumatoid corneal ulcerations.

(2003) Ophthalmic Res. 35(3):143-149
Porstmann AU, Zwingenberger K, Pleyer U, Baatz H
Effects of a New Immunotherapeutic (CG5601) on Endotoxin-induced Uveitis.

2002

(2002) Ophthalmologe 99:289-294
Puchta J, Pleyer U, Reszka R, Baatz H
Makrophagendepletion hemmt die Leukozytenrekrutierung bei experimenteller Melanininduzierter Uveitis (EMIU).

(2002) ARVO Ft. Lauderdale, Florida, USA
Porstmann AU, Zwingenberger K, Pleyer U, Hartmann C, Baatz H
Effects of a Potential New Immunotherapeutic (CG5601) on Endotoxin-induced Uveitis.

2001

(2001) Exp Eye Res. 73:101-109
Baatz H, Puchta J, Reszka R, Pleyer U
Macrophage Depletion Prevents Leukocyte Adhesion and Disease Induction in Experimental Melanin-protein Induced Uveitis.

(2001) Ophthalmic Res. 33:256-263
Baatz H, Tönneßen B, Prada J, Pleyer U
Thalidomide Inhibits Leukocyte-Endothelium Interaction in Endotoxin-Induced Uveitis.

(2001) Ophthalmologe 98:731-735
Kojetinsky C, Baatz H, Pleyer U, Hartmann C, Rieck P
In-vitro Untersuchungen an bovinen und humanen Linsenepithelzellkulturen zur Nachstarhemmung mittels eines zyklischen RGD-Peptids.

(2001) Inflammation Research 50:534-543
Baatz H, Pleyer U
Modulation of leukocyte-endothelium interaction by nitric oxide synthase inhibitors: Effects on leukocyte adhesion in endotoxin-induced uveitis.

(2001) Invest Ophthalmol Vis Sci. 42:S328
Schellenbeck M, Anders N, Baatz H.
Primary pterygia but not pseudopterygia are linked to a chronic stimulus of angiogenesis.

(2001) Invest Ophthalmol Vis Sci. 42:S914
Puchta J, Pleyer U, Reszka R, Baatz H.
Suppression of Experimental Melanin-Induced Uveitis (EMIU) after macrophage depletion with liposomal clodronate.

(2001) Ophthalmic Res (Suppl. 1) 33:37
Schellenbeck M, Anders N, Hartmann C, Baatz H
Primary Pterygia and their Recurrences: The Role of VEGF as a stimulus of Angiogenesis.

(2001) Der Augenspiegel 46:8-15
Baatz H
Uveitis – Leitlinien zur Diagnostik und Therapie.

2000

(2000) J Cataract Refract Surg 26:114-7
Prada J; Ngo-Tu T; Baatz H; Hartmann C; Pleyer U
Detection of tumor necrosis factor alpha and interleukin 1 alpha gene expression in human lens epithelial cells.

(2000) Graefes Arch Clin Exp Ophthalmol 238:88-93
Klotz O, Park J-K, Pleyer U, Hartmann C, Baatz H.
Inhibition of corneal neovascularization by -Integrin Antagonists in the Rat.

(2000) Invest Ophthalmol Vis Sci. 41:S130
Schellenbeck M, Anders N, Pleyer U, Hartmann C, Baatz H.
Detection of VEGF protein and VEGF receptor proteins FLK-1 and FLT-1 in pterygia.

(2000) Invest Ophthalmol Vis Sci. 41:S670
Prada J, Ngo-Tu T, Schründer S, Baatz H, Hartmann C, Pleyer U.
Gene expression of proinflammatory cytokines after excimer laser ablation in rat corneas.

(2000) Der Ophthalmologe (Suppl. 1) 97:S96
Puchta J., Pleyer U., Reszka R., Baatz H.
Makrophagendepletion mit liposomalem Clodronat hemmt die Leukozyten-Endothel-Interaktion bei Experimenteller Melanininduzierter Uveitis (EMIU).

(2000) Der Ophthalmologe (Suppl. 1) 97:S96
Velhagen K.-H., Kaduk S., Baatz H.
Operationsgebnisse bei exogener Endophthalmitis an der Charité-Augenklinik von 1988-1999

(2000) Der Ophthalmologe (Suppl. 1) 97:S132
Schellenbeck M., Anders N., Jürgensen J. S., Hartmann C., Baatz H.
VEGF und VEGF-Rezeptoren in Pterygien: Immunhistochemische Lokalisation und Western-Blot-Analyse.

(2000) Der Ophthalmologe (Suppl. 1) 97:S164
Baatz H., Velhagen K.-H.
Aravind: Die größte Katarakt-Klinik der Welt.

1999

(1999) Klin Monatsbl Augenheilkd 214:160-170
Pleyer U, Liekfeld A, Baatz H, Hartmann C.
Pharmakologische Modulation immunmediierter Erkrankungen am Auge.

(1999) Contactologica 21:164-171
Pleyer U, Baatz H, Lechner S.
Immunology of the tear film.

(1999) Am J Ophthalmol 128:506-507
Pleyer U, Sherif Z, Baatz H, Hartmann, C.
Delayed mustard gas keratopathy: Clinical findings and Confocal Microscopy.

(1999) Invest Ophthalmol Vis Sci. 40:S
Baatz H, Edelmann B, Pleyer U, Hartmann C.
Effects of Nitric Oxide Synthase Inhibitors on Leukocyte Adhesion in Endotoxin-Induced Uveitis.

(1999) Invest Ophthalmol Vis Sci. 40:S
Puchta J, Baatz H, Pleyer U, Hartmann C.
Leukocyte-Endothelium Interaction in Experimental Melanin-Induced Uveitis.

(1999) Invest Ophthalmol Vis Sci. 40:S
Fritzsche C, Rieck P, Baatz H, Pleyer U, Hartmann C.
Inhibition of Lens Epithelial Cell Adhesion in vitro by Short-term Incubation of a Cyclo-RGD-Peptide.

(1999) Invest Ophthalmol Vis Sci. 40:S
Prada J, Pleyer U, Ngo-Tu T, Baatz H, Rieck P, Hartmann C.
Gene Expression of Interleukin 1 and Tumor Necrosis Factor in Human Lens Epithelial Cells during Cataract Surgery.

(1999) EVER, Mallorca
Torun N, Priem S, Liekfeld A, Baatz H, Jaeckel C, Hartmann C, Pleyer U.
Uveitis: etiology and Disease Associations in a Tertiary Eye Care Center.

(1999) EVER, Mallorca
Baatz H, Puchta J, Pleyer U, Hartmann C.
Leukocyte-Endothelium Interaction in Experimental Melanin-Induced Uveitis.

(1999) EVER, Mallorca
Prada J, Noelle B, Baatz H, Hartmann C, Pleyer U.
TNF and IL 6 Gene Expression in Keratocytes from Patients with Corneal Ulcerations Associated with Rheumatoid Arthritis.

(1999) Der Ophthalmologe (Suppl. 1) 96:S131
Torun N, Priem S, Liekfeld A, Baatz H, Jaeckel C.
Uveitis: Epidemiologie und Zuweisungsmuster an einer Universitäts-Augenklinik.

(1999) Der Ophthalmologe (Suppl. 1) 96:S132
Baatz H, Pleyer U, Hartmann C.
Modulation der Leukozytenadhäsion durch NO-Antagonisten.

(1999) Der Ophthalmologe (Suppl. 1) 96:S170
Fritzsche C, Rieck P, Baatz H.
In Vitro Untersuchungen an bovinen und humanen Linsenepithelzellkulturen zur Adhäsionsinhibition mittels eines zyklischen RGD-Peptids.

(1999) Klin Monatsbl Augenheilkd 215 (Suppl. 12):1
Nimsgern C, Baatz H, Müller B, Tetz M.
Differentialdiagnose Papillenprominenz anhand des Camurati-Engelmann Syndroms.

1998

(1998) Invest Ophthalmol Vis Sci. 39:S894
Baatz H, Klotz O, Prada J, Pleyer U, Hartmann C.
A cyclic RGD-Peptide inhibits bFGf-induced Corneal Neovascularization, but not Corneal Neovascularization induced by chemical cauterization.

(1998) Invest Ophthalmol Vis Sci. 39:S894
Baatz H, Klotz O, Prada J, Pleyer U, Hartmann C.
Inhibition or enhancement of Corneal Neovascularization: Dose-specific action of Antibody directed against V 3-Integrin.

(1998) Ocular Immunol Inflam. 6:S17
Baatz H, Pleyer U, Tönneßen B, Hartmann C.
Antiinflammatory action of Thalidomide: Modulation of Leukocyte-Endothelium Interaction.

(1998) J Vasc Res. 35 (Suppl. 2):54 (Selected for poster discussion)
Baatz H, Pleyer U, Tönneßen B, Hartmann C.
Antiinflammatory action of Thalidomide: Modulation of Leukocyte-Endothelium Interaction.

(1998) J Vasc Res. 35 (Suppl. 2):75
Klotz O, Baatz H, Pleyer U, Hartmann C.
Inhibitory effects of V-Integrin Antagonists on Angiogenesis Induced by bFGF or Chemical Burn.

(1998) Der Ophthalmologe (Suppl. 1) 95:S131
Baatz H, Klotz O, Pleyer U, Hartmann C.
Hemmung kornealer Neovaskularisation durch V-Integrin Antagonisten.

(1998) Ophthalmic Res. 30 (Suppl. 1):82
Prada J, Baatz H, Klotz O, Pleyer U, Hartmann C.
Reduction of bFGF-induced neovascularization in rat corneas, after treatment with a cyclic RGD peptide antagonist to V 3-Integrin, is associated with downregulation of NO accumulation, TNF production and IL8/CINC gene expression.

1997

(1997) Ophthalmologica 211(Suppl 1):2-8
Pleyer U, Baatz H.
Antibacterial Protection of the Ocular Surface.

(1997) Transplantation 63:460-465
Seehofer D, Baatz H, Thiery J, Müller-Höcker J, Müller-Derlich J, Hammer C.
Fluorescence Videomicroscopic Assessment of Xenogeneic Microcirculation and Impact of Antibody Removal by Immunoabsorption.

(1997) Invest Ophthalmol Vis Sci. 38:S1159
Baatz H, Tönneßen B, Pleyer U, Hartmann C.
Thalidomide inhibits Leukocyte-Endothelium-Interaction in Endotoxin-Induced Uveitis.

(1997) Invest Ophthalmol Vis Sci. 38:S189
Prada J, Baatz H, Haberland A, Coupland S, Klebe S, Pleyer U, Hartmann C.
Immunohistochemical Localization of iNOS Expression in Endotoxin-Induced Uveitis.

(1997) Invest Ophthalmol Vis Sci. 38:S1051
Tönneßen B, Baatz H, Rüther K, Pleyer U, Hartmann C.
Hemodynamic and Physiological Parameters in Intravital Microscopy of Iris vessels.

(1997) Der Ophthalmologe (Suppl. 1) 94:S193
Baatz H, Tönneßen B, Pleyer U, Hartmann C.
Antiinflammatorische Wirkung von Thalidomid: Hemmung der Leukozyten -Endothel-Interaktion bei Endotoxin-Induzierter Uveitis.

1996

(1996) Transplant Proc 28:724-725
Seehofer D, Baatz H, Thiery J, Hammer C.
Intravital Microscopy for Evaluation of Early Xenograft Viability of Isolated Perfused Rat Livers.

(1996) Ophthalmologe 93:749-75
Baatz H, Pleyer U, Hammer C, Thiel H-J.
Scheinbare Wandscherrate und Leukozyten-Endothel-Interaktion in Irisgefäßen bei Endotoxin-induzierter Uveitis.

(1996) Invest Ophthalmol Vis Sci. 37:S38
Baatz H, Steinbauer M, Harris AG, Krombach F.
Rhodamine 6G for in vivo visualization of leukocytes: Intensity and retention of fluorescence in subpopulations

(1996) Int J Microcirc. 16 (S1):120
Baatz H, Steinbauer M, Harris AG, Krombach F.
Rhodamine 6G as a stain for white blood cells in rats, mice and hamsters.

(1996) Int J Microcirc. 16 (S1):205
Seehofer D, Baatz H, Müller-Derlich J, Müller-Höcker J, Hammer C.
Hepatic microcirculatory disturbances during hyperacute xenogeneic rejection: Quantitative analysis by intravital microscopy.

(1996) Der Ophthalmologe (Suppl. 1) 93:S96
Baatz H, Pleyer U, Dörner T, Feist E, Hartmann C, Burmester G.
Uveitis und Phospholipid-abhängige Anti- 2-Glykoprotein I (Anti- 2 GPI)-Antikörper

(1996) Der Ophthalmologe (Suppl. 1) 93:S101
Velhagen KH, Pleyer U, Döcke W, Baatz H, Rieck P, Hartmann C.
Postoperative Endophthalmitis: Analyse pro- und antiinflammatorischer Zytokine.

(1996) Der Ophthalmologe (Suppl. 1) 93:S68
Müller M, Baatz H, Pleyer U, Hartmann C.
Endothelzelldichte und -polymegathismus bei Uveitis.

(1996) Der Ophthalmologe (Suppl. 1) 93:S84
Bergmann L, Pleyer U, Baatz H, Pham DT, Hartmann C.
Okuläre Beteiligung bei zwei hereditären Formen der Epidermolysis bullosa.

(1996) Vision Research 36:S215
Baatz H, Tettschlag C, Haberland A, Pleyer U, Hartmann C.
Automated Cell Tracking and Velocity Measurement for Intravital Microscopy.

(1996) Klin Montsbl Augenheikd 209 Suppl 3:11
Baatz H, Pleyer U, Hartmann C.
Aktueller Stand der Entwicklung von Strategien zur Hemmung der Neovaskularisation am Auge.

1995

(1995) Baatz H, Pleyer U, Thiel H-J, Hammer C., In Vivo Study of Leukocyte-Endothelium Interaction in Endotoxin-Induced Uveitis. Invest Ophthalmol Vis Sci. 36:1960-1967.

(1995) Baatz H, Steinbauer M, Harris AG, Krombach F., Kinetics of White Blood Cell Staining by Intravascular Administration of Rhodamine 6G. Int J Microcirc. 15:85-91.

(1995) Baatz H, Pleyer U, Hammer C., Visualization of Leukocyte-Endothelium Interaction in Endotoxin-induced Uveitis. 6th Walter Brendel Symposium on Applied Immunology and Microcirculation. European Surgical Research 27:419.

(1995) Baatz H, Pleyer U, Hammer C, Leukocyte-Endothelium Interaction in Postcapillary Iris Venules with Varying Diameter. Invest Ophthalmol Vis Sci. 36:S551.

(1995) Baatz H, Pleyer U, Hammer C, Thiel H-J., Scheinbare Wandscherrate und Leukozyten-Endothel-Interaktion in Irisgefäßen. Der Ophthalmologe (Suppl. 1) 92:S116.

(1995) Baatz H, Pleyer U, Filler G, Hartmann C., Akute interstitielle Nephritis und Uveitis: TINU-Syndrom. Klinische Monatsblätter für Augenheilkunde (Sonderdruck) S12.

1994

(1994) Baatz H, Pleyer U, Hammer C, Thiel H-J.
Intravitale Fluoreszenzmikroskopie der Iris bei Endotoxin- Induzierter Uveitis: Beobachtung der Leukozyten-Endothel-Interaktion in vivo. Der Ophthalmologe (Suppl. 1) 91:S11.

1992

(1992) Bone Mineral (Suppl. 1)17:30
Rüger JM, Baatz H, Sommerfeld D, Pannike A
Matrix vesicles in the mineralisation of induced bone.